Arriving in the landscape of obesity therapy, retatrutide represents a unique strategy. Unlike many existing medications, retatrutide functions as a dual agonist, concurrently affecting both GLP-like peptide-1 (GLP-1) https://charlieaogz230836.gynoblog.com/37541412/the-new-retatrutide-a-glp-gip-receptor-agonist